Whiteout:
How Racial Capital Changed
the Color of Heroin in America
Helena Hansen, MD, Ph.D.
Professor of Psychiatry
Chair, Research Theme in Translational Social Science
UCLA David Geffen School of Medicine
Technologies of Whiteness
Buprenorphine Patients in U.S.:
91% White, 56% College Educated
Buprenorphine Methadone
Geography of Buprenorphine is the
Inverse of Methadone Distribution
Whiteness
Exclusive category -> boundary maintenance
Unmarked: assumed norm
Defined by its “Other:” Black/White interdependent
Costly (to Whites)
Technologies of Whiteness
Addiction Neuroscience
New Biotechnologies
Regulatory Structures
Marketing
Technologies of Whiteness
Addiction Neuroscience
Decade of the Brain 1990-1999
By the President of the United States of America
A PROCLAMATION
The human brain, a 3-pound mass of interwoven nerve cells that controls our
Technologies of Whiteness
New Biotechnologies
Technologies of Whiteness
Regulation
Technologies of Whiteness
Media and Marketing
1. Magic Bullets are a Myth
Buprenorphine Treatment and Opioid Overdose in France
(Auriacombe et al Am J Addiction 2004)
2. Problem Drug Use is Bio-Social
3. Deaths of Despair Call for Racial
and Economic Justice
Technologies of Whiteness
1.Universal, comprehensive healthcare
1.Universal, comprehensive healthcare
2. Nationally end criminalization, promote
harm reduction and treatment
1.Universal, comprehensive healthcare
2. Nationally end criminalization, promote
harm reduction and treatment
3. Bio-Social and Systems Research and
Interventions
Acknowledgments
NIDA K01 Award Program
RWJ Health Policy Investigator Award Program
RWJ Health and Society Scholar’s Program
APA/SAMHSA Minority Fellowship
NYU Anthropology Department
NYU Psychiatry Department
NY State Office of Mental Health Nathan Kline
Institute